Healthcare >> Analyst Interviews >> March 18, 2022

Biotechs That Battle Infection Meet a Growing Need

Brozak, Steve
Steve Brozak is the Managing Partner and President of WBB Securities, LLC. In 2013, Dr. Brozak was selected as a top analyst in the pharmaceuticals sector by the StarMine/Financial Times Industry Analyst Awards. He also was named to The Wall Street Journal’s “Best on the Street” list in the category of medical equipment and supplies. Earlier, Dr. Brozak worked in finance at Alex. Brown & Sons, Cowen & Company, Dean Witter and Salomon Brothers. Dr. Brozak has written for Nature, The British Medical Journal and Brain Stimulation. He is also a contributor to Forbes and ABC News. He received a B.A. degree and an MBA from Columbia University and a Doctorate in Medical Humanities — DMH — from Drew University. He served in the United States Marine Corps, retiring as a lieutenant colonel. Profile
Word count: 1,870

TWST: You’ve received many awards and accolades for your investment acumen — you usually get it right. To what do you attribute your success?

Dr.